The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse AZD3355 Dose-escalation Study in Healthy Males
- collapse TLESR-impedance Study in Patients
- collapse Drug Interaction Study Between AZD3355 and Nexium
- collapse Symptom Improvements in GERD Patients
- collapse Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms (C27)
- collapse Renal Impairment Study
- collapse A cross-sectional study on the prevalence of GERD in primary care patients with upper GI symptoms using the GERD-Q. The Bulgarian GERD-Q Study.
- collapse Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)
- collapse Omeprazole and Ranitidine in the Treatment of Patients with Erosive Esophagitis Not Responding to Treatment withH2-Receptor Antagonists: A Double-Blind, Controlled, Multicentre study.
- collapse Omeprazole in the Long-Term Management of Duodenal Ulcers – A comparative study of omeprazole and ranitidine in high risk duodenal ulcer disease.
